11.0.0.0 Prev. Ad­mis­sions & Read­mis­sions

11.1.0.0 Pre­vent­ing Hy­po­glycemic Ad­mis­sions in Older Adults

In­sulin-‍treat­ed pa­tients 80 years of age or older are more than twice as like­ly to visit the emer­gen­cy de­part­ment and near­ly five times as like­ly to be ad­mit­ted for in­sulin-‍re­lat­ed hy­po­glycemia than those 45–64 years of age (83). How­ev­er, older adults with type 2 di­a­betes in long-‍term care fa­cil­i­ties tak­ing ei­ther oral an­ti­hy­per­glycemic agents or basal in­sulin have sim­i­lar glycemic con­trol (84), sug­gest­ing that oral ther­a­py may be used in place of in­sulin to lower the risk of hy­po­glycemia for some pa­tients. In ad­di­tion, many older adults with di­a­betes are overtreat­ed (85), with half of those main­tain­ing an A1C <7% (53 mmol/‍mol) being treat­ed with in­sulin or a sul­fony­lurea, which are as­so­ci­at­ed with hy­po­glycemia. To fur­ther lower the risk of hy­po­glycemia-‍re­lat­ed ad­mis­sions in older adults, pro­viders may, on an in­di­vid­u­al basis, relax A1C tar­gets to 8% (64 mmol/‍mol) or 8.5% (69 mmol/‍mol) in pa­tients with short­ened life ex­pectan­cies and significant co­mor­bidi­ties (refer to Sec­tion 12 “Older Adults” for de­tailed cri­te­ria).